The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Cyclooxygenase-2 and Epidermal Growth Factor Receptor: Pharmacologic Targets for Chemoprevention
Abstract
Understanding the mechanisms underlying carcinogenesis provides insights that are necessary for the development of therapeutic strategies to prevent cancer. Chemoprevention, the use of drugs or natural substances to inhibit carcinogenesis, is a rapidly evolving aspect of cancer research. Evidence is presented that cyclooxygenase-2 (COX-2) and epidermal growth factor receptor (EGFR) are potential pharmacologic targets to prevent cancer. In this paper, we review key data implicating a causal relationship between COX-2, EGFR, and carcinogenesis and possible mechanisms of action. We discuss evidence of crosstalk between COX-2 and EGFR in order to strengthen the rationale for combination chemoprevention, and review plans for a clinical trial that will evaluate the concept of combination chemoprevention targeting COX-2 and EGFR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
DNA Content as a Prognostic Marker in Patients with Oral Leukoplakia
Sudbø, J., Kildal, W., Risberg, B., Koppang, H. S., Danielsen, H. E., & Reith, A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104263441702 · Cited by 285
RetractedRETRACTED: The Influence of Resection and Aneuploidy on Mortality in Oral Leukoplakia
Sudbø, J., Lippman, S. M., Lee, J. J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033374 · Cited by 109
Self-citationRetractedSlamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc839 · Cited by 6,056
Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,027
Cyclooxygenases: Structural, cellular, and molecular biology
Smith, W. L., DeWitt, D. L., & Garavito, R. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.145 · Cited by 2,925
The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
Steinbach, G., Lynch, P. M., Phillips, R. K. S., Wallace, M. H., Hawk, E., Gordon, G. B., Wakabayashi, N., Saunders, B., Shen, Y., Fujimura, T., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006293422603 · Cited by 2,526
Self-citationUp-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S., & Dubois, R. N. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90246-1 · Cited by 2,514
Self-citationGlobal cancer statistics in the year 2000
Parkin, D. M. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(01)00486-7 · Cited by 2,445
Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., & Taketo, M. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81988-1 · Cited by 2,366
Cyclooxygenase regulates angiogenesis induced by colon cancer cells
Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., & DuBois, R. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81433-6 · Cited by 2,272
Self-citationTsujii, M., & DuBois, R. N. (1995) · Cell · doi:10.1016/0092-8674(95)90127-2 · Cited by 2,267
Self-citationCohen, S. (1962) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83739-0 · Cited by 2,193
Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents
Kurumbail, R. G., Stevens, A. M., Gierse, J. K., McDonald, J. J., Stegeman, R. A., Pak, J. Y., Gildehaus, D., iyashiro, J. M., Penning, T. D., Seibert, K., et al. (1996) · Nature · doi:10.1038/384644a0 · Cited by 1,917
Signal Transduction through MAP Kinase Cascades
(1998) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60765-4 · Cited by 1,759
Risk of Cardiovascular Events Associated with Selective COX-2 Inhibitors
Mukherjee, D. (2001) · JAMA · doi:10.1001/jama.286.8.954 · Cited by 1,741
Treatment of Colonic and Rectal Adenomas with Sulindac in Familial Adenomatous Polyposis
Giardiello, F. M., Hamilton, S. R., Krush, A. J., Piantadosi, S., Hylind, L. M., Celano, P., Booker, S. V., Robinson, C. R., & Offerhaus, G. J. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305063281805 · Cited by 1,717
Prenzel, N., Zwick, E., Daub, H., Leserer, M., Abraham, R., Wallasch, C., & Ullrich, A. (1999) · Nature · doi:10.1038/47260 · Cited by 1,504
Hirsch, F. R., Varella-Garcia, M., Bunn, P. A., Di Maria, M. V., Veve, R., Bremnes, R. M., Barón, A. E., Zeng, C., & Franklin, W. A. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.069 · Cited by 1,477
Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells.
Sheng, H., Shao, J., Morrow, J. D., Beauchamp, R. D., & Dubois, R. N. (1998) · PubMed · Cited by 1,114
Self-citationColorectal cancer prevention and treatment by inhibition of cyclooxygenase-2
Gupta, R. A., & DuBois, R. N. (2001) · Nature Reviews Cancer · doi:10.1038/35094017 · Cited by 1,066
Self-citationCell Proliferation in Carcinogenesis
Cohen, S. M., & Ellwein, L. B. (1990) · Science · doi:10.1126/science.2204108 · Cited by 1,050
Kawamori, T., Rao, C. V., Seibert, K., & Reddy, B. S. (1998) · PubMed · Cited by 916
COX-2 is expressed in human pulmonary, colonic, and mammary tumors
Soslow, R. A., Dannenberg, A. J., Rush, D., Woerner, B. M., Khan, K. N., Masferrer, J., & Koki, A. T. (2000) · Cancer · doi:10.1002/1097-0142(20001215)89:12<2637::aid-cncr17>3.0.co;2-b · Cited by 862
Self-citationGrandis, J. R., & Tweardy, D. J. (1993) · PubMed · Cited by 851
Pai, R., Soreghan, B., Szabo, I. L., Pavelka, M., Baatar, D., & Tarnawski, A. S. (2002) · Nature Medicine · doi:10.1038/nm0302-289 · Cited by 836
Baselga, J., Rischin, D., Ranson, M., Calvert, H., Raymond, E., Kieback, D. G., Kaye, S. B., Gianni, L., Harris, A., Bjork, T., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.03.100 · Cited by 829
Expression of cyclooxygenase-2 in human gastric carcinoma.
Ristimäki, A., Honkanen, N., Jänkälä, H., Sipponen, P., & Härkönen, M. (1997) · PubMed · Cited by 813
Overexpression of Cyclooxygenase-2 Is Sufficient to Induce Tumorigenesis in Transgenic Mice
Liu, C. H., Chang, S.-H., Narko, K., Trifan, O. C., Wu, M.-T., Smith, E., Haudenschild, C., Lane, T. F., & Hla, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010787200 · Cited by 807
Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer.
Ristimaki, A. P., Sivula, A., Lundin, J. E., Lundin, M., Salminen, T. M., Haglund, C. H., Joensuu, H., & Isola, J. J. (2002) · PubMed · Cited by 780
Too Many Rodent Carcinogens: Mitogenesis Increases Mutagenesis
Ames, B. N., & Gold, L. S. (1990) · Science · doi:10.1126/science.2136249 · Cited by 770
Chan, T. O., Rittenhouse, S. E., & Tsichlis, P. N. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.965 · Cited by 737
Expression of cyclooxygenase-2 in human lung carcinoma.
Wolff, H. J., Saukkonen, K., Anttila, S. L., Karjalainen, A., Vainio, H., & Ristimaki, A. P. (1998) · PubMed · Cited by 717
Regulation of the immune response by prostaglandins
Goodwin, J. S., & Ceuppens, J. (1983) · Journal of Clinical Immunology · doi:10.1007/bf00915791 · Cited by 715
Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck.
Chan, G. G., Boyle, J. O., Yang, E. K., Zhang, F., Sacks, P. G., Shah, J. P., Edelstein, D. R., Soslow, R. A., Koki, A. T., Woerner, B. M., et al. (1999) · PubMed · Cited by 706
Self-citationCyclooxygenase-2 expression is up-regulated in human pancreatic cancer.
Tucker, O., Dannenberg, A. J., Yang, E. K., Zhang, F., Teng, L., Daly, J. M., Soslow, R. A., Masferrer, J. L., Woerner, B. M., Koki, A. T., et al. (1999) · PubMed · Cited by 692
Self-citationPrenzel, N., Fischer, O. M., Streit, S., Hart, S., & Ullrich, A. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080011 · Cited by 673
Cyclooxygenase-2 expression in human esophageal carcinoma.
Zimmermann, K. C., Sarbia, M., Weber, A., Borchard, F., Gabbert, H. E., & Schrör, K. (1999) · PubMed · Cited by 664
Prostaglandin E2 Increases Growth and Motility of Colorectal Carcinoma Cells
Sheng, H., Shao, J., Washington, M. K., & DuBois, R. N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009689200 · Cited by 653
Self-citationFrequent expression of a mutant epidermal growth factor receptor in multiple human tumors.
Moscatello, D. K., Holgado-Madruga, M., Godwin, A. K., Ramirez, G., Gunn, G. R., Zoltick, P. W., Biegel, J. A., Hayes, R. L., & Wong, A. J. (1995) · PubMed · Cited by 637
Goodwin, J. S., Bankhurst, A. D., & Messner, R. P. (1977) · The Journal of experimental medicine · doi:10.1084/jem.146.6.1719 · Cited by 635
Wilson, K. T., Fu, S., Ramanujam, K. S., & Meltzer, S. J. (1998) · PubMed · Cited by 591
Buckman, S. (1998) · Carcinogenesis · doi:10.1093/carcin/19.5.723 · Cited by 590
Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice
Sonoshita, M., Takaku, K., Sasaki, N., Sugimoto, Y., Ushikubi, F., Narumiya, S., Oshima, M., & Taketo, M. M. (2001) · Nature Medicine · doi:10.1038/nm0901-1048 · Cited by 587
Ben-Av, P., Crofford, L. J., Wilder, R. L., & Hla, T. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00956-a · Cited by 566
Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor.
Harris, R. E., Alshafie, G. A., Abou‐Issa, H., & Seibert, K. (2000) · PubMed · Cited by 540
Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer
Dannenberg, A. J., Altorki, N. K., Boyle, J. O., Dang, C., Howe, L. R., Weksler, B. B., & Subbaramaiah, K. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(01)00488-0 · Cited by 508
Self-citationGenetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice.
Chulada, P. C., Thompson, M. B., Mahler, J. F., Doyle, C. M., Gaul, B. W., Lee, C., Tiano, H. F., Morham, S. G., Smithies, O., & Langenbach, R. J. (2000) · PubMed · Cited by 496
Combinatorial chemoprevention of intestinal neoplasia
Torrance, C. J., Jackson, P. E., Montgomery, E., Kinzler, K. W., Vogelstein, B., Wissner, A., Nunes, M., Frost, P., & Discafani, C. M. (2000) · Nature Medicine · doi:10.1038/79534 · Cited by 493
Huang, M., Stolina, M., Sharma, S. P., Mao, J. T., Zhu, L. X., Miller, P. W., Wollman, J. S., Herschman, H. R., & Dubinett, S. M. (1998) · PubMed · Cited by 492
Inoue, H., Yokoyama, C., Hara, S., Tone, Y., & Tanabe, T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24965 · Cited by 479
Jacoby, R. F., Seibert, K., Cole, C. E., Kelloff, G. J., & Lubet, R. A. (2000) · PubMed · Cited by 478
Stolina, M., Sharma, S., Lin, Y., Dohadwala, M., Gardner, B., Luo, J., Zhu, L., Kronenberg, M., Miller, P. W., Portanova, J., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.361 · Cited by 465
Buchanan, F. G., Wang, D., Bargiacchi, F., & DuBois, R. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302474200 · Cited by 463
Self-citationTargeting cyclooxygenase-2 in human neoplasia
Dannenberg, A. J., & Subbaramaiah, K. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00310-6 · Cited by 446
Self-citationDixon, D. A., Tolley, N. D., King, P. H., Nabors, L. B., McIntyre, T. M., Zimmerman, G. A., & Prescott, S. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12973 · Cited by 444
Zhao, Y. D., Agarwal, V. R., Mendelson, C. R., & Simpson, E. R. (1996) · Endocrinology · doi:10.1210/en.137.12.5739 · Cited by 434
Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells.
Subbaramaiah, K., TELANG, N. T., Ramonetti, J. T., Araki, R., DeVito, B., Weksler, B. B., & Dannenberg, A. J. (1996) · PubMed · Cited by 418
Self-citationExpression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer.
Dassonville, O., Formento, J. L., Francoual, M., Ramaioli, A., Santini, J., Schneider, M., Demard, F., & Milano, G. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.10.1873 · Cited by 415
Fischer, S. M., Lo, H.-H., Gordon, G. B., Seibert, K., Kelloff, G., Lubet, R. A., & Conti, C. J. (1999) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199908)25:4<231::aid-mc1>3.0.co;2-f · Cited by 408
Koga, H., Sakisaka, S., Ohishi, M., Kawaguchi, T., Taniguchi, E., Sasatomi, K., Harada, M., Kusaba, T., Tanaka, M., Kimura, R., et al. (1999) · Hepatology · doi:10.1002/hep.510290355 · Cited by 396
Liu, D., Ghiso, J. A. A., Estrada, Y., & Ossowski, L. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00072-7 · Cited by 392
Developing Inhibitors of the Epidermal Growth Factor Receptor for Cancer Treatment
Grunwald, V., & Hidalgo, M. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.12.851 · Cited by 383
Leese, P. T., Hubbard, R. C., Karim, A., Isakson, P. C., Yu, S. S., & Geis, G. S. (2000) · The Journal of Clinical Pharmacology · doi:10.1177/00912700022008766 · Cited by 371
Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis.
Mutoh, M., Watanabe, K., Kitamura, T., Shoji, Y., Takahashi, M., Kawamori, T., Tani, K., Kobayashi, M., Maruyama, T., Kobayashi, K., et al. (2002) · PubMed · Cited by 362
Inhibition of Cyclooxygenase-2 Gene Expression by p53
Subbaramaiah, K., Altorki, N., Chung, W. J., Mestre, J. R., Sampat, A., & Dannenberg, A. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10911 · Cited by 355
Self-citationPost-transcriptional Control of Cyclooxygenase-2 Gene Expression
Dixon, D. A., Kaplan, C. D., McIntyre, T. M., Zimmerman, G. A., & Prescott, S. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.11750 · Cited by 349
Buttar, N. S., Wang, K. K., Leontovich, O., Westcott, J. Y., Pacifico, R. J., Anderson, M. A., Krishnadath, K. K., Lutzke, L. S., & Burgart, L. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.32371 · Cited by 348
Evans, J. F., Oshima, M., Murai, N., Kargman, S., Arguello, M., Luk, P., Kwong, E., & Taketo, M. M. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.02780.x · Cited by 333
Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents?
Gasparini, G., Longo, R., Sarmiento, R., & Morabito, A. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01220-8 · Cited by 330
Cyclooxygenase-2 is overexpressed in human cervical cancer.
Kulkarni, S., Rader, J. S., Zhang, F., Liapis, H., Koki, A. T., Masferrer, J. L., Subbaramaiah, K., & Dannenberg, A. J. (2001) · PubMed · Cited by 328
Self-citationHost Prostaglandin E2-EP3 Signaling Regulates Tumor-Associated Angiogenesis and Tumor Growth
Amano, H., Hayashi, I., Endo, H., Kitasato, H., Yamashina, S., Maruyama, T., Kobayashi, M., Satoh, K., Narita, M., Sugimoto, Y., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021408 · Cited by 325
Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
Araki, Y., Okamura, S., Hussain, S. P., Nagashima, M., He, P., Shiseki, M., Miura, K., & Harris, C. C. (2003) · PubMed · Cited by 322
Cyclooxygenase-2 Is Overexpressed in HER-2/neu-positive Breast Cancer
Subbaramaiah, K., Norton, L., Gerald, W., & Dannenberg, A. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111415200 · Cited by 317
Self-citationFujino, H., West, K. A., & Regan, J. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109440200 · Cited by 310
Thromboxane A2 is a mediator of COX-2 dependent endothelial migration & angiogenesis
Daniel, T. O., Liu, H., Morrow, J. D., Crews, B. C., & Mamett, L. J. (1999) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(99)90300-3 · Cited by 307
Microtubule-interfering Agents Stimulate the Transcription of Cyclooxygenase-2
Subbaramaiah, K., Hart, J. C., Norton, L., & Dannenberg, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.20.14838 · Cited by 300
Self-citationThromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis.
Daniel, T. O., Liu, H., Morrow, J. D., et al. (1999) · PubMed · Cited by 295
Xie, W., & Herschman, H. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27622 · Cited by 288
Mohammed, S. I., Knapp, D. W., Bostwick, D. G., Foster, R. S., Khan, K. N. M., Masferrer, J. L., Woerner, B. M., Snyder, P. W., & Koki, A. T. (1999) · PubMed · Cited by 285
Roberts, R. B., Min, L., Washington, M. K., Olsen, S. J., Settle, S. H., Coffey, R. J., & Threadgill, D. W. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032678499 · Cited by 275
Altorki, N. K., Keresztes, R. S., Port, J. L., Libby, D. M., Korst, R. J., Flieder, D. B., Ferrara, C. A., Yankelevitz, D. F., Subbaramaiah, K., Pasmantier, M. W., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.127 · Cited by 275
Self-citationZhang, X., Morham, S. G., Langenbach, R., & Young, D. A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.4.451 · Cited by 273
Albanell, J., Codony‐Servat, J., Rojo, F., Campo, J. M. D., Sauleda, S., Anido, J., Raspall, G., Giralt, J., Roselló, J., Nicholson, R. I., et al. (2001) · PubMed · Cited by 273
Sung, J. J. Y., Leung, W. K., Go, M. Y. Y., To, K. F., Cheng, A. S. L., Ng, E. K. W., & Chan, F. K. L. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64586-5 · Cited by 265
Yang, L., Yamagata, N., Yadav, R., Brandon, S., Courtney, R. L., Morrow, J. D., Shyr, Y., Boothby, M., Joyce, S., Carbone, D. P., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16492 · Cited by 250
Tumor cyclooxygenase 2-dependent suppression of dendritic cell function.
Sharma, S. P., Stolina, M., Yang, S.-C., Baratelli, F. E., Lin, J. F.-H., Atianzar, K., Luo, J., Zhu, L., Lin, Y., Huang, M., et al. (2003) · PubMed · Cited by 232
White, W. B., Faich, G., Whelton, A., Maurath, C., Ridge, N. J., Verburg, K. M., Geis, G. S., & Lefkowith, J. B. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02265-2 · Cited by 230
Howe, L. R., Subbaramaiah, K., Patel, J. A., Masferrer, J. L., Deora, A., Hudis, C. A., Thaler, H. T., Muller, W. J., Du, B., Brown, A. M. C., et al. (2002) · PubMed · Cited by 219
Self-citationMolecular Markers of the Risk of Oral Cancer
Lippman, S. M., & Hong, W. K. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104263441710 · Cited by 213
Self-citationRisk of cardiovascular events associated with selective COX-2 inhibitors
Mukherjee, D., Nissen, S. E., & Topol, E. J. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00545-1 · Cited by 208
Hirsch, F. R., Scagliotti, G. V., Langer, C. J., Varella-Garcia, M., & Franklin, W. A. (2003) · Lung Cancer · doi:10.1016/s0169-5002(03)00137-5 · Cited by 208
Dihydroxy Bile Acids Activate the Transcription of Cyclooxygenase-2
Zhang, F., Subbaramaiah, K., Altorki, N., & Dannenberg, A. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.2424 · Cited by 204
Self-citationPrevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398.
Rioux, N., & Castonguay, A. (1998) · PubMed · Cited by 204
Neufang, G., Fürstenberger, G., Heidt, M., Marks, F., & Müller-Decker, K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121574098 · Cited by 204
Regulation of Cyclooxygenase-2 Expression by the Translational Silencer TIA-1
Dixon, D. A., Balch, G. C., Kedersha, N., Anderson, P., Zimmerman, G. A., Beauchamp, R. D., & Prescott, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030616 · Cited by 197
Oral Cancer Prevention and the Evolution of Molecular-Targeted Drug Development
Lippman, S. M., Sudbø, J., & Hong, W. K. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.128 · Cited by 185
Self-citationKondo, M., Yamamoto, H., Nagano, H., Okami, J., Ito, Y., Shimizu, J., Eguchi, H., Miyamoto, A., Dono, K., Umeshita, K., et al. (1999) · PubMed · Cited by 176
Prostaglandin E2 stimulates the growth of colon cancer cells via induction of amphiregulin.
Shao, J., Lee, S. B., Guo, H., Evers, B. M., & Sheng, H. (2003) · PubMed · Cited by 175
Carcinogen substrate specificity of human COX-1 and COX-2
Wiese, F. W. (2001) · Carcinogenesis · doi:10.1093/carcin/22.1.5 · Cited by 164
Higuchi, T., Iwama∥, T., Yoshinaga, K., Toyooka, M., Taketo, M. M., & Sugihara, K. (2003) · PubMed · Cited by 151
Rusch, V. W., Klimstra, D. S., Linkov, I., & Dmitrovsky, E. (1995) · PubMed · Cited by 150
Tortora, G., Caputo, R., Damiano, V., Melisi, D., Bianco, R., Fontanini, G., Veneziani, B. M., Placido, S. D., Bianco, A. R., & Ciardiello, F. (2003) · PubMed · Cited by 150
Tristetraprolin Binds to the 3′-Untranslated Region of Cyclooxygenase-2 mRNA
Sawaoka, H., Dixon, D. A., Oates, J. A., & Boutaud, O. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300016200 · Cited by 144
Moraitis, D., Du, B., Lorenzo, M. S. D., Boyle, J. O., Weksler, B. B., Cohen, E. G., Carew, J. F., Altorki, N. K., Kopelovich, L., Subbaramaiah, K., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.664.65.2 · Cited by 141
Self-citationShirahama, T. (2000) · PubMed · Cited by 133
Tong, B. J., Tan, J., Tajeda, L., Das, S. K., Chapman, J. A., DuBois, R. N., & Dey, S. K. (2000) · Neoplasia · doi:10.1038/sj.neo.7900119 · Cited by 130
Self-citationLenferink, A. E. G., Simpson, J. F., Shawver, L. K., Coffey, R. J., Forbes, J. T., & Arteaga, C. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160564197 · Cited by 124
Prostaglandin-H-synthase isozyme expression in normal and neoplastic human skin
M�ller-Decker, K., Reinerth, G., Krieg, P., Zimmermann, R., Heise, H., Bayerl, C., Marks, F., & F�rstenberger, G. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990827)82:5<648::aid-ijc6>3.0.co;2-d · Cited by 116
Shiotani, H., Denda, A., Yamamoto, K., Kitayama, W., Endoh, T., Sasaki, Y., Tsutsumi, N., Sugimura, M., & Konishi, Y. (2001) · PubMed · Cited by 112
Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer
Leung, W. K., To, K., Ng, Y.-P., Lee, T.-L., Lau, J. Y. W., Chan, F. K. L., Ng, E. K. W., Chung, S., & Sung, J. J. �. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1607 · Cited by 109
Increased epidermal growth factor receptor expression in metaplastic bronchial epithelium.
Kurie, J. M., Shin, H. J. C., Lee, J. S., Morice, R., Ro, J. Y., Lippman, S. M., Hittelman, W. N., Ren, Y. T., Lee, J. J., & Hong, W. K. (1996) · PubMed · Cited by 107
Self-citationEvidence for the epidermal growth factor receptor as a target for lung cancer prevention.
Lonardo, F., Dragnev, K. H., Freemantle, S. J., Ma, Y., Memoli, N., Sekula, D., Knauth, E. A., BEEBE, J. S., & Dmitrovsky, E. (2002) · PubMed · Cited by 98
Golijanin, D., Tan, J., Kazior, A., Cohen, E. G., Russo, P., Dalbagni, G. M., Auborn, K. J., Subbaramaiah, K., & Dannenberg, A. J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1032-3 · Cited by 96
Self-citationRahme, E., Barkun, A. N., Toubouti, Y. M., & Bardou, M. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00880-1 · Cited by 92
Lü, C., Speers, C. W., Zhang, Y., Xu, X., Hill, J. L., Steinbis, E., Celestino, J., Shen, Q., Kim, H., Hilsenbeck, S. G., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg117 · Cited by 89
de Gregorio, R., Iñiguez, M. A., Fresno, M., & Alemany, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100885200 · Cited by 82
Microsomal prostaglandin E synthase-1 is overexpressed in head and neck squamous cell carcinoma.
Cohen, E. G., Almahmeed, T., Du, B., Golijanin, D., Boyle, J. O., Soslow, R. A., Subbaramaiah, K., & Dannenberg, A. J. (2003) · PubMed · Cited by 63
Self-citationHwang, D. H., Fung, V., & Dannenberg, A. J. (2002) · Neoplasia · doi:10.1038/sj.neo.7900226 · Cited by 56
Self-citationDNA CONTENT AS A PROGNOSTIC MARKER IN PATIENTS WITH ORAL LEUKOPLAKIA
Ildal, W. A. K., Isberg, B. J. R., Oppang, H. A. S. K., Anielsen, E. D., & Eith, R. (2006) · Cited by 41
Lung cancer prevention: retinoids and the epidermal growth factor receptor-a phoenix rising?
Averbuch, S. D. (2002) · PubMed · Cited by 28
Mohammed, S. I., Foster, R. S., Khan, N., Koki, A. T., Snyder, P. W., & Knapp, D. W. (1999) · The Journal of Urology · doi:10.1097/00005392-199904020-00268 · Cited by 16
Cited by
Cyclooxygenase‐2 in cancer: A review
Hashemi Goradel, N., Najafi, M., Salehi, E., Farhood, B., & Mortezaee, K. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27411 · Cited by 807
Aggarwal, B. B., Vijayalekshmi, R. V., & Sung, B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0149 · Cited by 795
Mediators of vascular remodelling co-opted for sequential steps in lung metastasis
Gupta, G. P., Nguyen, D. X., Chiang, A. C., Bos, P. D., Kim, J. Y., Nadal, C., Gomis, R. R., Manova-Todorova, K., & Massagué, J. (2007) · Nature · doi:10.1038/nature05760 · Cited by 727
Toll-Like Receptor-4 Promotes the Development of Colitis-Associated Colorectal Tumors
Fukata, M., Chen, A., Vamadevan, A. S., Cohen, J., Breglio, K., Krishnareddy, S., Hsu, D., Xu, R., Harpaz, N., Dannenberg, A. J., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.09.008 · Cited by 621
Self-citationChemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases
Zorzi, D., Laurent, A., Pawlik, T. M., Lauwers, G. Y., Vauthey, J.-N., & Abdalla, E. K. (2007) · British Journal of Surgery · doi:10.1002/bjs.5719 · Cited by 532
Metadata
- Authors
- Dannenberg, A. J., Lippman, S. M., Mann, J. R., Subbaramaiah, K., & DuBois, R. N.
- Venue
- Journal of Clinical Oncology
- Published
- 2005-01-10
- Volume
- 23
- Issue
- 2
- Pages
- 254-266
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1975560535
- Cited by
- 404
- References
- 122
- FWCI
- 32.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.